165 related articles for article (PubMed ID: 35331118)
1. Diagnostic Dilemmas and Current Treatment Approaches in Latent Onset Autoimmune Diabetes in Adults: A Concise Review.
Chandran L; Singh S A; Vellapandian C
Curr Diabetes Rev; 2023; 19(1):e240322202561. PubMed ID: 35331118
[TBL] [Abstract][Full Text] [Related]
2. Autoimmunity-Associated PTPN22 Polymorphisms in Latent Autoimmune Diabetes of the Adult Differ from Those of Type 1 Diabetes Patients.
Heneberg P; Kocková L; Čecháková M; Daňková P; Černá M
Int Arch Allergy Immunol; 2018; 177(1):57-68. PubMed ID: 29895027
[TBL] [Abstract][Full Text] [Related]
3. Current view of diagnosis and treatment of latent autoimmune diabetes in adults.
Urbanová J; Brunerová L; Malinovská J; Pelechová B; Koberová L; Brož J
Vnitr Lek; 2021; 67(2):97-102. PubMed ID: 34074108
[TBL] [Abstract][Full Text] [Related]
4. Adult-onset autoimmune diabetes: current knowledge and implications for management.
Buzzetti R; Zampetti S; Maddaloni E
Nat Rev Endocrinol; 2017 Nov; 13(11):674-686. PubMed ID: 28885622
[TBL] [Abstract][Full Text] [Related]
5. Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain.
Mollo A; Hernandez M; Marsal JR; Esquerda A; Rius F; Blanco-Vaca F; Verdaguer J; Pozzilli P; de Leiva A; Mauricio D;
Diabetes Metab Res Rev; 2013 Sep; 29(6):446-51. PubMed ID: 23483713
[TBL] [Abstract][Full Text] [Related]
6. Fatty Acid Profiles and Their Association With Autoimmunity, Insulin Sensitivity and β Cell Function in Latent Autoimmune Diabetes in Adults.
Tian H; Wang S; Deng Y; Xing Y; Zhao L; Zhang X; Zhang P; Liu N; Su B
Front Endocrinol (Lausanne); 2022; 13():916981. PubMed ID: 35846301
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Latent Autoimmune Diabetes in Adults: What is Best?
Hals IK
Curr Diabetes Rev; 2019; 15(3):188-193. PubMed ID: 30009709
[TBL] [Abstract][Full Text] [Related]
8. Type 1 Diabetes-related Autoantibodies in Different Forms of Diabetes.
Sørgjerd EP
Curr Diabetes Rev; 2019; 15(3):199-204. PubMed ID: 30058495
[TBL] [Abstract][Full Text] [Related]
9. Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes.
Jones AG; McDonald TJ; Shields BM; Hagopian W; Hattersley AT
Diabetes Care; 2021 Jun; 44(6):1243-1251. PubMed ID: 34016607
[TBL] [Abstract][Full Text] [Related]
10. Latent autoimmune diabetes in youth shows greater autoimmunity than latent autoimmune diabetes in adults: Evidence from a nationwide, multicenter, cross-sectional study.
Cheng J; Tang X; Yan X; Huang G; Luo S; Zhou Z; Li X
Pediatr Diabetes; 2022 Aug; 23(5):578-587. PubMed ID: 35451144
[TBL] [Abstract][Full Text] [Related]
11. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel.
Buzzetti R; Tuomi T; Mauricio D; Pietropaolo M; Zhou Z; Pozzilli P; Leslie RD
Diabetes; 2020 Oct; 69(10):2037-2047. PubMed ID: 32847960
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea.
Roh MO; Jung CH; Kim BY; Mok JO; Kim CH
Acta Diabetol; 2013 Apr; 50(2):129-34. PubMed ID: 20953640
[TBL] [Abstract][Full Text] [Related]
13. Insulin autoantibody could help to screen latent autoimmune diabetes in adults in phenotypic type 2 diabetes mellitus in Chinese.
Huang G; Wang X; Li Z; Li H; Li X; Zhou Z
Acta Diabetol; 2012 Oct; 49(5):327-31. PubMed ID: 20473693
[TBL] [Abstract][Full Text] [Related]
14. [Features of the development of latent autoimmune diabetes in adults (LADA)].
Timakova AA; Saltykov BB
Arkh Patol; 2019; 81(4):78-82. PubMed ID: 31407723
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelin profiling in patients with diabetes could be potentially useful as differential diagnostics biomarker: A pilot study.
Sokołowska E; Car H; Fiedorowicz A; Szelachowska M; Milewska A; Wawrusiewicz-Kurylonek N; Szumowski P; Krzyżanowska-Grycel E; Popławska-Kita A; Żendzian-Piotrowska M; Chabowski A; Krętowski A; Siewko K
Adv Med Sci; 2022 Sep; 67(2):250-256. PubMed ID: 35785598
[TBL] [Abstract][Full Text] [Related]
16. Low C-peptide together with a high glutamic acid decarboxylase autoantibody level predicts progression to insulin dependence in latent autoimmune diabetes in adults: The HUNT study.
Sørgjerd EP; Åsvold BO; Grill V
Diabetes Obes Metab; 2021 Nov; 23(11):2539-2550. PubMed ID: 34318969
[TBL] [Abstract][Full Text] [Related]
17. A Case Report of Latent Autoimmune Diabetes Arising After Isotretinoin Treatment: Real Association or Coincidence? A Hypothesis on Pathophysiology.
Bozkuş Y
Endocr Metab Immune Disord Drug Targets; 2021; 21(12):2307-2310. PubMed ID: 34259153
[TBL] [Abstract][Full Text] [Related]
18. [Latent autoimmune diabetes in adults: an update].
Zhou ZG; Li X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):630-4. PubMed ID: 14650175
[TBL] [Abstract][Full Text] [Related]
19. A Review on Latent Autoimmune Diabetes in Adults.
Ravikumar V; Ahmed A; Anjankar A
Cureus; 2023 Oct; 15(10):e47915. PubMed ID: 38034250
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study.
Vich-Pérez P; Abánades-Herranz JC; Mora-Navarro G; Carrasco-Sayalero ÁM; Salinero-Fort MÁ; Sevilla-Machuca I; Sanz-Pascual M; Álvarez Hernández-Cañizares C; de Burgos-Lunar C;
PLoS One; 2023; 18(2):e0281657. PubMed ID: 36758065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
